Zylox-Tonbridge Medical Technology Co., Ltd.
HKEX:2190.HK
11.02 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 527.754 | 334.09 | 177.912 | 27.631 | 4.917 |
| Cost of Revenue
| 142.766 | 81.421 | 46.031 | 11.344 | 3.725 |
| Gross Profit
| 384.988 | 252.669 | 131.881 | 16.287 | 1.192 |
| Gross Profit Ratio
| 0.729 | 0.756 | 0.741 | 0.589 | 0.242 |
| Reseach & Development Expenses
| 261.013 | 233.461 | 168.1 | 72.065 | 53.028 |
| General & Administrative Expenses
| 114.088 | 109.337 | 100.599 | 30.992 | 16.962 |
| Selling & Marketing Expenses
| 163.827 | 140.137 | 95.269 | 20.453 | 6.759 |
| SG&A
| 277.915 | 249.474 | 195.868 | 51.445 | 23.721 |
| Other Expenses
| -3.213 | -8.08 | -14.03 | -9.44 | -6.614 |
| Operating Expenses
| 529.422 | 474.855 | 349.938 | 114.07 | 70.135 |
| Operating Income
| -156.523 | -222.186 | -218.057 | -97.783 | -68.943 |
| Operating Income Ratio
| -0.297 | -0.665 | -1.226 | -3.539 | -14.021 |
| Total Other Income Expenses Net
| 77.789 | 94.843 | 12.787 | -0.306 | -0.946 |
| Income Before Tax
| -78.734 | -113.555 | -199.689 | -100.468 | -66.647 |
| Income Before Tax Ratio
| -0.149 | -0.34 | -1.122 | -3.636 | -13.554 |
| Income Tax Expense
| 88.16 | 6.852 | -13.638 | -0.986 | -1.886 |
| Net Income
| -78.734 | -120.407 | -186.051 | -99.482 | -64.761 |
| Net Income Ratio
| -0.149 | -0.36 | -1.046 | -3.6 | -13.171 |
| EPS
| -0.24 | -0.36 | -0.63 | -0.31 | -0.2 |
| EPS Diluted
| -0.24 | -0.36 | -0.63 | -0.31 | -0.2 |
| EBITDA
| -41.603 | -86.565 | -199.945 | -90.164 | -58.96 |
| EBITDA Ratio
| -0.062 | -0.239 | -1.124 | -3.323 | -11.991 |